Investigating treatments for CKD possess anti-inflammatory properties that might contribute to their previously established clinical benefits, including renin-angiotensin-aldosterone system inhibitors, sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists and non-steroidal mineralocorticoid antagonists, possess anti-inflammatory properties that might contribute to their previously established clinical benefits.
Renin–angiotensin system inhibitors, sodium–glucose cotransporter-2 inhibitors, finerenone, and glucagon-like peptide-1 receptor agonists improve cardiorenal outcomes and have plausible anti-inflammatory actions, although inflammatory mediation remains unproven.
Aris Tsalouchos, P. Dattolo· Journal of Clinical Medicine· 0 citations
An overview of the key signaling pathways and molecular mediators that underlie typical pathophysiological processes in diabetic kidney disease is presented and central role of transforming growth factor-beta in activating various signaling pathways is noted.
O. A. Nagibovich, A. L. Kovalenko, O. S. Ketlinskaya· Nephrology (Saint-Petersburg...· 0 citations
Abstract Coronary microvascular dysfunction (CMD) is a major underlying cause of myocardial ischaemia and is associated with adverse cardiovascular outcomes. It occurs both in the presence of obstructive coronary artery disease (CAD) and in patients with non-obstructive CAD. Emerging evidence highlights chronic inflamm...
Wan-Qi Wang, M. Magistri, John F. Beltrame et al.· European Heart Journal Open· 0 citations
BACKGROUND. Vascular and cardiac calcification is an important contributor to cardiovascular complications in patients with chronic kidney disease (CKD) and is associated with oxidative stress and persistent low-grade inflammation. However, the interactions between these processes and their contribution to cardiovascul...
F. Dzgoeva, I. В. Tedety, O. Remizov et al.· Nephrology (Saint-Petersburg...· 0 citations
Chronic kidney disease (CKD) is a global health problem, especially in the elderly, leading to renal failure through gradual progression and chronic inflammation, in addition to increasing cardiovascular risk. MicroRNAs (miRNAs), non-coding RNAs that regulate gene expression, act as chemical messengers and have been...
Maria Tereza de Oliveira Rodrigues, Abigail Holanda Pierre da Nobrega, R. Neves et al.· Scientific Reports· 0 citations
Chronic Kidney Disease (CKD) poses a growing global health burden, with increasing prevalence driven by risk factors such as aging, metabolic disorders, and environmental influences. As CKD progresses, it frequently leads to renal fibrosis, a pathological condition characterized by excessive extracellular matrix (ECM)...
A. Doghish, Khaled Abuelhaded, M. M. Abdelaziz et al.· International Journal of Bio...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.